These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33239423)

  • 1. A Whole Blood Enzyme-Linked Immunospot Assay for Functional Immune Endotyping of Septic Patients.
    Mazer MB; C Caldwell C; Hanson J; Mannion D; Turnbull IR; Drewry A; Osborne D; Walton A; Blood T; Moldawer LL; Brakenridge S; Remy KE; Hotchkiss RS
    J Immunol; 2021 Jan; 206(1):23-36. PubMed ID: 33239423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEMPORAL CHANGES IN INNATE AND ADAPTIVE IMMUNITY DURING SEPSIS AS DETERMINED BY ELISPOT.
    Unsinger J; Osborne D; Walton AH; Han E; Sheets L; Mazer MB; Remy KE; Griffith TS; Rao M; Badovinac VP; Brakenridge SC; Turnbull I; Efron PA; Moldawer LL; Caldwell CC; Hotchkiss RS
    Shock; 2024 Aug; 62(2):255-264. PubMed ID: 38754032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and optimization of a diluted whole blood ELISpot assay to test immune function.
    Ungaro RF; Xu J; Kucaba TA; Rao M; Bergmann CB; Brakenridge SC; Efron PA; Goodman MD; Gould RW; Hotchkiss RS; Liang M; Mazer MB; McGonagill PW; Moldawer LL; Remy KE; Turnbull IR; Caldwell CC; Badovinac VP; Griffith TS
    J Immunol Methods; 2024 Oct; 533():113743. PubMed ID: 39147231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Changes in Innate and Adaptive Immunity During Sepsis as Determined by ELISpot.
    Unsinger J; Osborne D; Walton AH; Han E; Sheets L; Mazer MB; Remy KE; Griffith TS; Rao M; Badovinac VP; Brackenridge SC; Turnbull I; Efron PA; Moldawer LL; Caldwell CC; Hotchkiss RS
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Rapid Cytokine Immunoassays for Functional Immune Phenotyping.
    Bonavia AS; Samuelsen A; Chroneos ZC; Halstead ES
    Front Immunol; 2022; 13():940030. PubMed ID: 35860253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients.
    Mazer M; Unsinger J; Drewry A; Walton A; Osborne D; Blood T; Hotchkiss R; Remy KE
    J Immunol; 2019 Oct; 203(8):2088-2099. PubMed ID: 31501258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot.
    Barrios EL; Mazer MB; McGonagill PW; Bergmann CB; Goodman MD; Gould RW; Rao M; Polcz VE; Davis RJ; Del Toro DE; Dirain ML; Dram A; Hale LO; Heidarian M; Kim CY; Kucaba TA; Lanz JP; McCray AE; Meszaros S; Miles S; Nelson CR; Rocha IL; Silva EE; Ungaro RF; Walton AH; Xu J; Zeumer-Spataro L; Drewry AM; Liang M; Bible LE; Loftus TJ; Turnbull IR; Efron PA; Remy KE; Brakenridge SC; Badovinac VP; Griffith TS; Moldawer LL; Hotchkiss RS; Caldwell CC
    JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38100268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay.
    Sedegah M
    Methods Mol Biol; 2015; 1325():197-205. PubMed ID: 26450390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTL ELISPOT Assay and T Cell Detection.
    Ranieri E; Netti GS; Gigante M
    Methods Mol Biol; 2021; 2325():65-77. PubMed ID: 34053051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Coxiella burnetii infection: comparison of a whole blood interferon-gamma production assay and a Coxiella ELISPOT.
    Schoffelen T; Limonard GJ; Bleeker-Rovers CP; Bouwman JJ; van der Meer JW; Nabuurs-Franssen M; Sprong T; van Deuren M
    PLoS One; 2014; 9(8):e103749. PubMed ID: 25084353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTL ELISPOT assay.
    Ranieri E; Popescu I; Gigante M
    Methods Mol Biol; 2014; 1186():75-86. PubMed ID: 25149304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Organ Dysfunction in Septic and Critically Ill Patients: A Prospective Cohort Study Using Rapid Ex Vivo Immune Profiling.
    Samuelsen AM; Halstead ES; Lehman EB; McKeone DJ; Bonavia AS
    Crit Care Explor; 2024 Jul; 6(7):e1106. PubMed ID: 38916619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of whole blood cytokine immunoassays for rapid, functional immune phenotyping in critically ill patients with sepsis.
    Bonavia AS; Samuelsen A; Liang M; Hanson J; McKeone D; Chroneos ZC; Halstead ES
    Intensive Care Med Exp; 2023 Oct; 11(1):70. PubMed ID: 37831231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Evaluation of an ELISPOT Assay Using Cytokine Activity as a Novel Parameter.
    Maeda C; Iizuka A; Miyata H; Kondou R; Ashizawa T; Kanematsu A; Watanabe K; Deguchi S; Mitsuya K; Hayashi N; Abe Y; Yamaguchi K; Akiyama Y
    Anticancer Res; 2021 Aug; 41(8):3825-3831. PubMed ID: 34281842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.
    Umlauf BJ; Haralambieva IH; Ovsyannikova IG; Kennedy RB; Pankratz VS; Jacobson RM; Poland GA
    Viral Immunol; 2012 Feb; 25(1):29-36. PubMed ID: 22239234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong interferon-gamma mediated cellular immunity to scrub typhus demonstrated using a novel whole cell antigen ELISpot assay in rhesus macaques and humans.
    Sumonwiriya M; Paris DH; Sunyakumthorn P; Anantatat T; Jenjaroen K; Chumseng S; Im-Erbsin R; Tanganuchitcharnchai A; Jintaworn S; Blacksell SD; Chowdhury FR; Kronsteiner B; Teparrukkul P; Burke RL; Lombardini ED; Richards AL; Mason CJ; Jones JW; Day NPJ; Dunachie SJ
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005846. PubMed ID: 28892515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.
    Ontiveros N; Tye-Din JA; Hardy MY; Anderson RP
    Clin Exp Immunol; 2014 Feb; 175(2):305-15. PubMed ID: 24192268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.
    Kato K; Kawase A; Azukizawa H; Hanafusa T; Nakagawa Y; Murota H; Sakaguchi S; Asada H; Katayama I
    J Dermatol Sci; 2017 Jun; 86(3):222-229. PubMed ID: 28330775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.